Medelpharm heads for Boston compaction simulation forum

Medelpharm heads for Boston compaction simulation forum

Medelpharm Logo

Press Release | MEDELPHARM S.A.S

JUNE 20, 2016

Beynost, France: – Research-based tablet press manufacturer and powder compaction specialists Medelpharm will share insights on its roller compaction simulation capabilities at the CSF forum in Boston, USA.

At CSF 2016, Medelpharm will exhibit its versatile Tableting Instrument, STYL’One Evolution that features a new Roller Compactor Pack and Rotary Press Library.

Leading force in compaction simulation

“For almost a decade now, Medelpharm has been a leading member of the Compaction Simulation Forum and a consistent participant and exhibitor at its annual meeting, which brings together experts and users of compaction simulators from the scientific community and pharmaceutical industry,” Ms. Coyle added.

“We are really looking forward to this chance to renew acquaintances with the leading experts in this important and rapidly expanding fields of roller compaction and simulation research and analysis,” she added.

Impact of feeding system

At the conference, Medelpharm junior scientist Susana Nieto will present a poster that shows how she used the latest STYL’One to study the impact of feeding System on tablet properties, using its capability to perform real time simulation of roller compaction.

“The CSF poster session offers an excellent platform for students from all over the world to present their work in a poster session and possibly attract international attention by winning the “Poster of the Year” award,” said Ingrid Coyle, International Sales & Business Development Director for Medelpharm.

About Medelpharm

Medelpharm, founded in 1985 and headquartered near Lyon in southeastern France, are specialist designer, developers and manufacturers of innovative solutions for R&D Tablet Presses and powder characterization services.

Medelpharm manufactures unique R&D laboratory tablet presses designed with style.

Medelpharm has shipped more than 100 instruments running in 4 continents, including:

  • STYLCAM Mechanical Rotary Press Simulator, the first Medelpharm patented machine, which has been running for 15 years
  • STYL’One Classic, the world fastest multilayer development press
  • STYL’One Evolution, the latest servo-mechanical compaction simulator

All presses are equipped with ANALIS, a proprietary data acquisition, control-and reporting system that incorporates multilayer, tab in tab functions as well as GMP-, production and automated research functions.

The company also offers a comprehensive range of Powder Compaction and Characterization Services in its laboratory within Lyon University, along with valuable troubleshooting and ongoing support services focused on reducing transposition and manufacturing costs and uncertainties in development while increasing production efficiency, regardless of final application.

About CSF 2016

Compaction Simulation Forum (CSF) is a web-based resource that provides a one stop resource where scientists, engineers, academics and equipment manufacturers can find and share the latest research, knowledge and technologies in roller compaction and particle size reduction.

The annual CSF Forum was formed almost a decade ago, envisaged as an open assembly where ideas and information on compression simulation can be exchanged between commerce, industry and academia. The event alternates between venues in Europe and North America.

CSF 2016 is a two-day event opening June 21 at the Omni Parker House Hotel in downtown Boston, featuring four keynote speakers and nine other presentations, as well as poster sessions.

More information at:

Media Contact

Ingrid Coyle, International Sales & Business Development Director, MEDELPHARM S.A.S.
Tel: +33 478 9762 13


Click on Medelpharm heads for Boston compaction simulation forum for other information.
Click on
MEDELPHARM to contact the company directly.

Supplier Information
Address: 12, rue des Petites Combes, Z.I. Nord, F-01700 Beynost, France
Tel: +33 478 976 213
Fax: +33 478 881 865

Comments are closed.